Icosavax, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2017-01-01
- Employees
- 60
- Market Cap
- -
- Website
- http://www.icosavax.com
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)โข Click on a phase to view related trials
A Study of IVX-A12 in Adults Participants
- Conditions
- Healthy Participants
- Interventions
- Biological: Licensed RSV Vaccine
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-08-26
- Lead Sponsor
- Icosavax, Inc.
- Target Recruit Count
- 143
- Registration Number
- NCT06481579
- Locations
- ๐บ๐ธ
Icosavax Investigational Site US022, Anaheim, California, United States
๐บ๐ธIcosavax Investigational Site US021, Rolling Hills Estates, California, United States
๐บ๐ธIcosavax Investigational Site US002, Hollywood, Florida, United States
A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age
- Conditions
- Healthy
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Icosavax, Inc.
- Target Recruit Count
- 264
- Registration Number
- NCT05903183
- Locations
- ๐บ๐ธ
AMR Phoenix, Tempe, Arizona, United States
๐บ๐ธCenexel RCA, Hollywood, Florida, United States
๐บ๐ธClinical Research Atlanta, Stockbridge, Georgia, United States
Safety and Immunogenicity of IVX-A12 in Healthy Older Adults
- Conditions
- Healthy
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Icosavax, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT05664334
- Locations
- ๐บ๐ธ
CenExcel RCA, Hollywood, Florida, United States
๐บ๐ธCenExcel ACMR, Atlanta, Georgia, United States
๐บ๐ธMeridien Clinical Research, Omaha, Nebraska, United States